Global Companion Diagnostic Tests in Oncology Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.



Scope of the Report:

This report studies the Companion Diagnostic Tests in Oncology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Companion Diagnostic Tests in Oncology market by product type and applications/end industries.

The global Companion Diagnostic Tests in Oncology market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Companion Diagnostic Tests in Oncology.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.



Market Segment by Companies, this report covers

Abbott

Roche

Genomic Health

QIAGEN

Agilent

Agendia

BioMerieux

Illumina

Siemens Healthcare

Thermo Fisher



Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

Protein Detection

DNA Detection



Market Segment by Applications, can be divided into

Pharmaceutical & Biotechnology Companies

Medical Device Companies

Research Institutes

Table of Contents



1 Companion Diagnostic Tests in Oncology Market Overview

1.1 Product Overview and Scope of Companion Diagnostic Tests in Oncology

1.2 Classification of Companion Diagnostic Tests in Oncology by Types

1.2.1 Global Companion Diagnostic Tests in Oncology Revenue Comparison by Types (2017-2023)

1.2.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Types in 2017

1.2.3 Protein Detection

1.2.4 DNA Detection

1.3 Global Companion Diagnostic Tests in Oncology Market by Application

1.3.1 Global Companion Diagnostic Tests in Oncology Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Pharmaceutical & Biotechnology Companies

1.3.3 Medical Device Companies

1.3.4 Research Institutes

1.4 Global Companion Diagnostic Tests in Oncology Market by Regions

1.4.1 Global Companion Diagnostic Tests in Oncology Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Companion Diagnostic Tests in Oncology Status and Prospect (2013-2023)

1.5 Global Market Size of Companion Diagnostic Tests in Oncology (2013-2023)

2 Manufacturers Profiles

2.1 Abbott

2.1.1 Business Overview

2.1.2 Companion Diagnostic Tests in Oncology Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.2 Roche

2.2.1 Business Overview

2.2.2 Companion Diagnostic Tests in Oncology Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.3 Genomic Health

2.3.1 Business Overview

2.3.2 Companion Diagnostic Tests in Oncology Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.4 QIAGEN

2.4.1 Business Overview

2.4.2 Companion Diagnostic Tests in Oncology Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.5 Agilent

2.5.1 Business Overview

2.5.2 Companion Diagnostic Tests in Oncology Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.6 Agendia

2.6.1 Business Overview

2.6.2 Companion Diagnostic Tests in Oncology Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.7 BioMerieux

2.7.1 Business Overview

2.7.2 Companion Diagnostic Tests in Oncology Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.8 Illumina

2.8.1 Business Overview

2.8.2 Companion Diagnostic Tests in Oncology Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.9 Siemens Healthcare

2.9.1 Business Overview

2.9.2 Companion Diagnostic Tests in Oncology Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

2.10 Thermo Fisher

2.10.1 Business Overview

2.10.2 Companion Diagnostic Tests in Oncology Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

3 Global Companion Diagnostic Tests in Oncology Market Competition, by Players

3.1 Global Companion Diagnostic Tests in Oncology Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Companion Diagnostic Tests in Oncology Players Market Share

3.2.2 Top 10 Companion Diagnostic Tests in Oncology Players Market Share

3.3 Market Competition Trend

4 Global Companion Diagnostic Tests in Oncology Market Size by Regions

4.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Regions

4.2 North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

4.3 Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

4.5 South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

5 North America Companion Diagnostic Tests in Oncology Revenue by Countries

5.1 North America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)

5.2 USA Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

5.3 Canada Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

5.4 Mexico Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

6 Europe Companion Diagnostic Tests in Oncology Revenue by Countries

6.1 Europe Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)

6.2 Germany Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

6.3 UK Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

6.4 France Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

6.5 Russia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

6.6 Italy Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue by Countries

7.1 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)

7.2 China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

7.3 Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

7.4 Korea Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

7.5 India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

8 South America Companion Diagnostic Tests in Oncology Revenue by Countries

8.1 South America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)

8.2 Brazil Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

8.3 Argentina Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

8.4 Colombia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Companion Diagnostic Tests in Oncology by Countries

9.1 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)

9.2 Saudi Arabia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

9.3 UAE Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

9.4 Egypt Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

9.5 Nigeria Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

9.6 South Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

10 Global Companion Diagnostic Tests in Oncology Market Segment by Type

10.1 Global Companion Diagnostic Tests in Oncology Revenue and Market Share by Type (2013-2018)

10.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Type (2018-2023)

10.3 Protein Detection Revenue Growth Rate (2013-2023)

10.4 DNA Detection Revenue Growth Rate (2013-2023)

11 Global Companion Diagnostic Tests in Oncology Market Segment by Application

11.1 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2013-2018)

11.2 Companion Diagnostic Tests in Oncology Market Forecast by Application (2018-2023)

11.3 Pharmaceutical & Biotechnology Companies Revenue Growth (2013-2018)

11.4 Medical Device Companies Revenue Growth (2013-2018)

11.5 Research Institutes Revenue Growth (2013-2018)

12 Global Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2023)

12.1 Global Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2023)

12.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Regions (2018-2023)

12.3 North America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

12.4 Europe Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

12.6 South America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Figures, Tables and Charts Available in Global Companion Diagnostic Tests in Oncology Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

List of Tables and Figures



Figure Companion Diagnostic Tests in Oncology Picture

Table Product Specifications of Companion Diagnostic Tests in Oncology

Table Global Companion Diagnostic Tests in Oncology and Revenue (Million USD) Market Split by Product Type

Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Types in 2017

Figure Protein Detection Picture

Figure DNA Detection Picture

Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Application (2013-2023)

Figure Companion Diagnostic Tests in Oncology Revenue Market Share by Applications in 2017

Figure Pharmaceutical & Biotechnology Companies Picture

Figure Medical Device Companies Picture

Figure Research Institutes Picture

Table Global Market Companion Diagnostic Tests in Oncology Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (2013-2023)

Table Abbott Basic Information, Manufacturing Base and Competitors

Table Abbott Companion Diagnostic Tests in Oncology Type and Applications

Table Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Companion Diagnostic Tests in Oncology Type and Applications

Table Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Genomic Health Basic Information, Manufacturing Base and Competitors

Table Genomic Health Companion Diagnostic Tests in Oncology Type and Applications

Table Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table QIAGEN Basic Information, Manufacturing Base and Competitors

Table QIAGEN Companion Diagnostic Tests in Oncology Type and Applications

Table QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Agilent Basic Information, Manufacturing Base and Competitors

Table Agilent Companion Diagnostic Tests in Oncology Type and Applications

Table Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Agendia Basic Information, Manufacturing Base and Competitors

Table Agendia Companion Diagnostic Tests in Oncology Type and Applications

Table Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table BioMerieux Basic Information, Manufacturing Base and Competitors

Table BioMerieux Companion Diagnostic Tests in Oncology Type and Applications

Table BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Illumina Basic Information, Manufacturing Base and Competitors

Table Illumina Companion Diagnostic Tests in Oncology Type and Applications

Table Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors

Table Siemens Healthcare Companion Diagnostic Tests in Oncology Type and Applications

Table Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Thermo Fisher Basic Information, Manufacturing Base and Competitors

Table Thermo Fisher Companion Diagnostic Tests in Oncology Type and Applications

Table Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2016-2017)

Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Players (2013-2018)

Table Global Companion Diagnostic Tests in Oncology Revenue Share by Players (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Players in 2016

Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Players in 2017

Figure Global Top 5 Players Companion Diagnostic Tests in Oncology Revenue Market Share in 2017

Figure Global Top 10 Players Companion Diagnostic Tests in Oncology Revenue Market Share in 2017

Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Regions (2013-2018)

Table Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Regions in 2017

Figure North America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Europe Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure South America Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Table North America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)

Table North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure North America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017

Figure USA Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Canada Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Mexico Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Table Europe Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018)

Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017

Figure Germany Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure UK Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure France Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Russia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Italy Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017

Figure China Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Japan Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Korea Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure India Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Table South America Companion Diagnostic Tests in Oncology Revenue by Countries (2013-2018)

Table South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure South America Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017

Figure Brazil Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Argentina Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Colombia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Companion Diagnostic Tests in Oncology Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Share by Countries in 2017

Figure Saudi Arabia Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure UAE Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Egypt Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure Nigeria Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Figure South Africa Companion Diagnostic Tests in Oncology Revenue and Growth Rate (2013-2018)

Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) by Type (2013-2018)

Table Global Companion Diagnostic Tests in Oncology Revenue Share by Type (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Type (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Type in 2017

Table Global Companion Diagnostic Tests in Oncology Revenue Forecast by Type (2018-2023)

Figure Global Companion Diagnostic Tests in Oncology Market Share Forecast by Type (2018-2023)

Figure Global Protein Detection Revenue Growth Rate (2013-2018)

Figure Global DNA Detection Revenue Growth Rate (2013-2018)

Table Global Companion Diagnostic Tests in Oncology Revenue by Application (2013-2018)

Table Global Companion Diagnostic Tests in Oncology Revenue Share by Application (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Application (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue Share by Application in 2017

Table Global Companion Diagnostic Tests in Oncology Revenue Forecast by Application (2018-2023)

Figure Global Companion Diagnostic Tests in Oncology Market Share Forecast by Application (2018-2023)

Figure Global Pharmaceutical & Biotechnology Companies Revenue Growth Rate (2013-2018)

Figure Global Medical Device Companies Revenue Growth Rate (2013-2018)

Figure Global Research Institutes Revenue Growth Rate (2013-2018)

Figure Global Companion Diagnostic Tests in Oncology Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Companion Diagnostic Tests in Oncology Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

Figure Europe Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

Figure South America Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Companion Diagnostic Tests in Oncology Revenue Market Forecast (2018-2023)

Keyplayers in Global Companion Diagnostic Tests in Oncology Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Abbott

Roche

Genomic Health

QIAGEN

Agilent

Agendia

BioMerieux

Illumina

Siemens Healthcare

Thermo Fisher